PT99720A - Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica - Google Patents

Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica

Info

Publication number
PT99720A
PT99720A PT99720A PT9972091A PT99720A PT 99720 A PT99720 A PT 99720A PT 99720 A PT99720 A PT 99720A PT 9972091 A PT9972091 A PT 9972091A PT 99720 A PT99720 A PT 99720A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
pharmacological activity
new pharmaceutical
preparing new
Prior art date
Application number
PT99720A
Other languages
English (en)
Other versions
PT99720B (pt
Inventor
Bengt Magnus Lindstedt
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PT99720A publication Critical patent/PT99720A/pt
Publication of PT99720B publication Critical patent/PT99720B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PT99720A 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica PT99720B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT99720A true PT99720A (pt) 1992-10-30
PT99720B PT99720B (pt) 2002-04-29

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99720A PT99720B (pt) 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica

Country Status (17)

Country Link
US (2) US5707656A (pt)
EP (1) EP0560816B1 (pt)
JP (1) JP3276956B2 (pt)
AT (1) ATE444737T1 (pt)
AU (1) AU656346B2 (pt)
CA (1) CA2097176C (pt)
DE (1) DE69133623D1 (pt)
EE (1) EE03105B1 (pt)
FI (1) FI932553A0 (pt)
HU (1) HU218661B (pt)
IE (1) IE914136A1 (pt)
IS (1) IS1749B (pt)
NO (1) NO305536B1 (pt)
PT (1) PT99720B (pt)
SE (1) SE9003903D0 (pt)
WO (1) WO1992010171A1 (pt)
YU (1) YU186791A (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313739T3 (es) * 1996-12-20 2009-03-01 Mcneil-Ppc, Inc. Farmacos antitusigeno administrados por medio de resinas de intercambio ionico.
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
WO2001008661A2 (en) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Opioid sustained-released formulation
DE60219478T2 (de) * 2001-07-06 2008-01-03 Endo Pharmaceuticals Inc. Orale gabe von 6-hydroxy-oxymorphon als analgetikum
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
US20090214625A1 (en) * 2005-07-15 2009-08-27 Mizuo Nakayama Drug delivery patch
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
JPWO2007026671A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
EP1925335A1 (en) * 2005-09-16 2008-05-28 Tti Ellebeau, Inc. Catheter type iontophoresis apparatus
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
CA2622777A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
JPWO2007037476A1 (ja) * 2005-09-30 2009-04-16 Ｔｔｉ・エルビュー株式会社 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
KR20110086799A (ko) * 2008-09-10 2011-08-01 트란스큐 리미티드 Ｈｐｃ-기재 점성질 액체를 다공성 기판에 주입하기 위한 기구 및 방법, 예를 들어 연속적 웹-기반 프로세스
WO2010115015A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
CA2097176A1 (en) 1992-06-08
FI932553L (fi) 1993-06-04
AU656346B2 (en) 1995-02-02
AU8930591A (en) 1992-07-08
IS1749B (is) 2000-07-11
EE03105B1 (et) 1998-08-17
YU186791A (sh) 1994-04-05
EP0560816A1 (en) 1993-09-22
CA2097176C (en) 2002-03-26
ATE444737T1 (de) 2009-10-15
HU9301671D0 (en) 1993-09-28
EP0560816B1 (en) 2009-10-07
US5707656A (en) 1998-01-13
SE9003903D0 (sv) 1990-12-07
JPH06503311A (ja) 1994-04-14
HUT64213A (en) 1993-12-28
HU218661B (hu) 2000-10-28
JP3276956B2 (ja) 2002-04-22
PT99720B (pt) 2002-04-29
US5709882A (en) 1998-01-20
IE914136A1 (en) 1992-06-17
NO305536B1 (no) 1999-06-21
NO932053D0 (no) 1993-06-04
IS3787A7 (is) 1992-06-08
NO932053L (no) 1993-07-20
WO1992010171A1 (en) 1992-06-25
FI932553A7 (fi) 1993-06-04
DE69133623D1 (de) 2009-11-19
FI932553A0 (fi) 1993-06-04

Similar Documents

Publication Publication Date Title
PT99720A (pt) Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ES2115231T3 (es) Emplasto con sustancias activas.
KR880001288A (ko) 경구투여 형태의 서방성 약제학적 조성물
ES2085337T3 (es) Comprimidos farmaceuticos.
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
EP0177893A3 (en) Sustained release dosage form based on highly plasticized cellulose ether gels
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES510245A0 (es) "un metodo para obtener una preparacion de insulina".
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
ES2127556T3 (es) Cuerpo de moldeo implantable para la administracion de sustancias activas a plantas.
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
UA6028A1 (uk) Спосіб одержання біологічно активної композиції
ES2007328A4 (es) Derivados de dihidropiridazinona, proceso de fabricacion y medicamentos con sus combinaciones
PT87737A (pt) Processo para a preparacao de composicoes farmaceuticas analgesicas contendo derivados de dioxopiperidina como substancia activa
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
IT1164389B (it) Derivati n-sostituiti dell'1-(4'-alchiltiofenil)-2-ammino-1,3-propandiolo
ES2015770A6 (es) Procedimiento de preparacion de acido (5r,6s)-2-carbamoiloximetil-6- (1r-hidroxietil)-2-penem carboxilico y sus formulaciones farmaceuticas
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
BR8904653A (pt) Processo para a producao de um baculovirus hibrido,bem como composicao inseticida
ATE66602T1 (de) Verwendung von nitrophenylgruppen zur stimulierung der inkorporationsfaehigkeit eines arzneimittels in die empfindlichen wirtszellen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920617

FG3A Patent granted, date of granting

Effective date: 20020115